Generic and biosimilar medications saved $467 billion in the U.S. healthcare system in 2024 alone, with $3.4 trillion saved over the past decade. These drugs make up 90% of prescriptions but only 12% of spending, proving they're the most powerful tool for cutting drug costs.
